Profluent
Programming biology with AI
Berkeley, United States · Founded 2022 · $150.0M raised
- Headquarters
- Berkeley, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- profluent.bio
- Total Funding
- $150.0M
- Last Round
- $106.0M Series BNov 2025
- Rounds
- 3
About
Profluent is a frontier AI company based in Berkeley applying deep generative models to protein design. ProGen models trained on billions of protein sequences enable programmable biology for drug development, gene editing, and industrial biotech. Created OpenCRISPR, the first AI-designed gene editor. Founded 2022.
Summary
Profluent is a Life Sciences company based in Berkeley, United States, founded in 2022. It has raised $150.0M in total across 3 rounds, most recently a $106.0M Series B round in Nov 2025.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...